v
l
b
l
e
w
w
w
c
e
n
c
e
r
e
c
c
j
u
r
n
l
h
e
p
g
e
w
w
w
e
l
e
v
e
r
h
e
l
h
c
j
u
r
n
l
travel
medicin
infecti
diseas
summari
first
identifi
human
hong
kong
influenza
known
commonli
avian
influenza
caus
human
diseas
countri
around
world
although
current
number
confirm
patient
tini
compar
season
recent
emerg
swine
influenza
remain
candid
next
highli
pathogen
influenza
pandem
current
limit
abil
spread
persontoperson
may
chang
mutat
reassort
influenza
virus
lead
influenza
pandem
high
mortal
occur
travel
like
affect
travel
medicin
doctor
need
consid
avian
influenza
return
febril
travel
earli
clinic
featur
may
dismiss
easili
flu
result
delay
treatment
treatment
option
limit
oral
oseltamivir
alon
commonli
use
drug
mortal
remain
substanti
indonesia
intraven
peramivir
file
registr
iv
zanamivir
develop
review
focu
epidemiolog
clinic
featur
influenza
avian
influenza
highlight
aspect
relev
travel
medicin
doctor
elsevi
ltd
right
reserv
avian
influenza
due
influenza
viru
emerg
potenti
global
threat
viru
join
list
respiratori
pathogen
emerg
past
year
often
caus
sever
clinic
diseas
like
legionella
pneumophila
sar
coronaviru
hanta
viru
pulmonari
syndrom
new
pathogen
emerg
caus
high
mortal
much
angst
gener
global
main
question
whether
potenti
effici
spread
persontoperson
therefor
risk
epidem
pandem
date
persontoperson
transmiss
rare
associ
close
human
contact
never
less
threat
remain
may
caus
next
pandem
substanti
mortal
global
spread
avian
influenza
poultri
trade
infect
bird
mani
countri
experienc
poultri
outbreak
fig
contrast
sar
epidem
current
pandem
swine
influenza
good
exampl
global
travel
play
import
role
spread
two
virus
acquir
abil
spread
easili
air
travel
would
effici
way
transport
infect
passeng
caus
outbreak
far
origin
sourc
infect
human
first
report
hong
kong
caus
death
confirm
patient
infect
poultri
hong
kong
wet
market
like
sourc
mass
cull
chicken
necessari
curtail
small
epidem
septemb
document
report
patient
countri
se
asia
wwwwhointcsr
indexhtm
access
novemb
infect
wild
bird
chicken
poultri
report
countri
africa
asia
europ
fig
histori
influenza
pandem
explain
anxieti
regard
three
pandem
influenza
past
year
one
upper
mind
pandem
size
high
total
mortal
million
peopl
patient
age
die
includ
young
adult
age
year
distinct
differ
usual
pattern
mortal
season
influenza
epidem
patient
extrem
age
suffer
greatest
mortal
lack
influenza
immun
import
reason
easi
spread
high
mortal
also
attribut
viral
gene
facilit
high
viral
load
excess
innat
inflammatori
respons
fatal
primari
viral
pneumonia
recent
reexamin
microbiolog
data
lung
tissu
suggest
strongli
secondari
bacteri
pneumonia
also
play
key
role
high
mortal
world
experienc
fourth
pandem
novel
influenza
viru
knowledg
infect
increas
import
lesson
learnt
may
impact
think
regard
one
theme
common
three
major
influenza
pandem
swine
flu
pandem
virus
respons
avian
link
pandem
thought
arisen
adapt
avian
like
influenza
viru
allow
easi
human
human
transmiss
wherea
pandem
pandem
influenza
virus
acquir
new
gene
eurasian
avian
virus
genet
reassort
circul
human
viru
swine
influenza
viru
assort
avian
human
swine
influenza
virus
current
highli
pathogen
avian
influenza
viru
continu
caus
outbreak
poultri
gain
abil
jump
speci
infect
human
mammal
travel
medicin
doctor
may
first
person
sick
patient
see
return
trip
oversea
although
still
rare
avian
influenza
need
differenti
diagnosi
return
febril
travel
travel
medicin
doctor
often
see
rare
diseas
captur
imagin
howev
romant
notion
forget
import
earli
defenc
potenti
spread
import
infecti
diseas
review
focu
aspect
pertin
travel
medicin
doctor
includ
epidemiolog
clinic
featur
diagnost
manag
patient
avian
influenza
human
influenza
well
known
caus
usual
selflimit
infect
upper
respiratori
tract
influenza
relat
mortal
confin
gener
young
elderli
immunocompromis
patient
underli
cardiorespiratori
ill
influenza
complic
notabl
secondari
bacteri
pneumonia
enceph
rhabdomyolysi
myocard
avian
influenza
import
contrast
featur
affect
individu
age
caus
frequent
sever
rapidli
progress
pneumon
high
mortal
even
fit
healthi
patient
mean
incub
period
day
report
rang
day
case
clinic
manifest
within
day
exposur
eg
sick
poultri
therefor
travel
easili
becom
symptomat
back
hisher
home
countri
visit
anoth
countri
may
occur
clinic
experi
publish
literatur
base
hospitalis
patient
clinic
pictur
bias
toward
greater
ill
sever
gener
individu
clinic
seri
small
patient
two
larger
studi
publish
recent
indonesia
n
z
vietnam
n
z
clearli
combin
dispar
databas
would
help
defin
better
clinic
featur
diseas
assess
robustli
poor
prognost
factor
enhanc
abil
conduct
clinic
research
knowledg
earli
stage
somewhat
scant
seri
hospitalis
patient
advanc
diseas
best
data
seri
kandun
et
al
major
patient
report
mild
prodrom
phase
characteris
fever
cough
runni
nose
minor
complain
earli
dyspnoea
clinic
pictur
may
easili
dismiss
common
cold
anoth
infecti
diseas
preval
set
result
patient
may
visit
sever
clinic
hospit
proverbi
penni
drop
time
delay
clinic
pictur
like
progress
significantli
cough
dyspnoea
domin
clinic
pictur
miss
diagnosi
patient
non
descript
febril
ill
new
travel
medicin
occur
patient
earli
malaria
diseas
often
place
first
differenti
diagnosi
fever
travel
prodrom
symptom
follow
increas
short
breath
may
becom
incapacit
within
sever
day
necessit
hospit
admiss
howev
minor
patient
develop
sever
diseas
otherwis
mild
cours
respond
well
oseltamivir
report
symptom
includ
myalgia
headach
vomit
diarrhoea
nausea
epigastr
pain
convuls
constip
physic
sign
depend
sever
ill
present
may
includ
fever
tachypnoea
dyspnoea
tachycardia
normal
low
blood
pressur
inspiratori
crepit
wheez
may
also
heard
less
frequent
crepit
sign
pleural
effus
may
also
present
experi
pneumothorac
gener
occur
mechan
noninvas
ventil
also
occur
non
ventil
patient
cutan
crepitu
may
found
human
data
possibl
occurr
induc
myocard
patient
deterior
clinic
degre
respiratori
failur
often
worsen
develop
acut
respiratori
distress
syndrom
ard
occur
day
median
day
ill
seen
acut
renal
failur
requir
haemofiltr
haemodialysi
classic
sign
acut
hepat
failur
patient
spontan
bleed
mucos
venepunctur
site
patient
usual
die
progress
respiratori
failur
number
also
inotrop
support
hypotens
death
occur
day
ill
patient
respond
favour
oseltamivir
clear
viru
die
ventil
associ
pneumonia
due
eg
multi
drug
resist
acinetobact
baumanii
although
predominantli
respiratori
ill
clinician
awar
atyp
nonrespiratori
present
case
report
document
child
first
present
sever
diarrhoea
follow
convuls
coma
adult
femal
present
gastroenter
follow
sever
pneumonia
die
full
blood
count
patient
show
either
normal
haemoglobin
mild
anaemia
white
cell
count
abnorm
common
leukopenia
defin
either
total
white
cell
count
occur
lymphopenia
year
year
degre
neutropenia
patient
vietnam
indonesia
sever
neutropenia
thrombocytopenia
platelet
count
common
sever
thrombocytopenia
affect
indonesian
patient
use
intern
societi
thrombosi
homeostasi
definit
dissemin
intravascular
coagul
present
patient
spontan
bleed
mucos
venepunctur
site
report
number
patient
may
rais
ddimer
normal
pt
aptt
low
normal
fibrinogen
concentr
consist
fibrinolysi
liver
enzym
gener
moder
elev
higher
ast
uln
valu
compar
alt
uln
valu
ast
alt
valu
exceed
respect
seen
patient
measur
lactat
dehydrogenas
ldh
also
high
uln
like
lung
origin
serum
creatinin
may
mild
moder
rais
urin
microscopi
report
unremark
asid
proteinuria
microscop
haematuria
creatinin
phosphokinas
cpk
may
rais
fold
upper
limit
normal
acut
rhabdomyolysi
myoglobinuria
renal
impair
yet
report
publish
data
cpkmb
fraction
cardiac
troponin
rais
blood
glucos
concentr
patient
without
known
diabet
mellitu
observ
present
consist
stress
induc
hyperglycaemia
hospit
admiss
usual
associ
steroid
use
requir
intraven
insulin
treatment
patient
pleural
fluid
may
straw
colour
haemorrhag
high
total
protein
ldh
concentr
meet
light
criteria
exud
may
posit
radiolog
radiograph
pneumonia
occur
almost
hospitalis
patient
chang
specif
chest
xray
cxr
shadow
includ
diffus
multifoc
patchi
infiltr
interstiti
infiltr
lobular
consolid
air
bronchogram
pneumothorac
pneumomediastina
sequenti
cxr
shadow
may
worsen
parallel
clinic
state
patient
fig
find
chest
ct
scan
consist
also
shown
destroy
lung
architectur
persist
ground
glass
attenu
segment
consolid
pseudocavit
pneumatocel
lymphadenopathi
centrilobular
nodul
post
recoveri
fibrosi
fig
mani
report
poor
prognost
factor
delay
oseltamivir
treatment
import
independ
factor
patient
indonesian
seri
mani
factor
robustli
test
independ
multivari
analys
probabl
use
clinic
pointer
admiss
leukopenia
lymphopenia
neutropenia
thrombocytopenia
ii
increas
ldh
admiss
iii
oseltamiviroth
antivir
treatment
iv
use
corticosteroid
v
bilater
cxr
shadow
vi
develop
ard
vii
blood
posit
viraemia
viii
high
cytokin
concentr
data
indonesia
suggest
hyperglycaemia
rais
ddimer
also
poor
prognost
factor
infect
caus
high
mortal
across
age
group
clinic
seri
younger
patient
experienc
higher
mortal
may
due
cross
protect
immun
previou
human
influenza
older
individu
main
rout
transmiss
poultri
human
probabl
via
respiratori
tract
eye
via
conjunctiv
mucosa
gut
possibl
rout
infect
gut
could
occur
lick
contamin
finger
swallow
water
contamin
poultri
infect
faec
poultri
excret
larg
amount
viru
faec
surviv
soil
water
poultri
faec
use
fertilis
fish
feed
countri
close
contact
chicken
direct
handl
infect
poultri
faec
repres
risk
factor
infect
outbreak
turkey
children
share
live
space
infect
chicken
se
asia
home
rear
poultri
common
chicken
duck
may
gather
deposit
faec
pond
commonli
use
children
bath
play
infect
poultri
may
appear
well
yet
excret
viru
environ
appar
healthi
poultri
pose
risk
infect
individu
visit
wet
market
fig
infect
poultri
sold
develop
one
week
later
determin
becam
infect
specul
could
selfinocul
respiratori
tract
touch
surfac
egg
inhal
aerosol
debri
contain
viru
human
human
transmiss
document
rare
usual
close
prolong
contact
person
famili
bloodlin
eg
father
son
nosocomi
transmiss
manifest
asymptomat
seroconvers
also
rare
obviat
need
good
infect
control
practic
importantli
quarter
patient
histori
high
risk
exposur
lack
histori
pretravel
advic
cosmopolitan
diseas
fig
three
countri
account
three
quarter
case
report
indonesia
vietnam
egypt
avian
virus
may
also
caus
outbreak
notabl
outbreak
holland
affect
individu
result
one
death
given
increas
awar
highli
pathogen
virus
like
corona
sar
recent
swine
flu
pandem
travel
like
ask
protect
overal
risk
travel
contract
low
current
travel
restrict
countri
bird
human
case
report
travel
recommend
carri
standbi
oseltamivir
nevertheless
remain
import
advis
individu
travel
awar
behaviour
exposur
led
diseas
local
popul
current
readili
avail
vaccin
number
receiv
regulatori
approv
vaccin
season
influenza
consid
travel
high
risk
influenza
complic
consist
mani
nation
guidelin
season
influenza
vaccin
offer
protect
travel
advis
data
emerg
swine
vaccin
gener
advic
box
includ
stay
away
dead
live
bird
poultri
like
chicken
turkey
gees
duck
quail
appli
especi
children
may
wish
play
new
found
friend
travel
end
wet
market
avoid
direct
contact
chicken
duck
egg
dirti
cage
slaughter
counter
etc
wise
take
photograph
distanc
use
zoom
function
might
sensibl
advic
well
cook
poultri
egg
pose
threat
health
viru
detect
raw
egg
good
hand
hygien
remain
import
prevent
measur
travel
may
wish
purchas
commerci
avail
hand
sanitis
effect
influenza
virus
travel
develop
febril
ill
hesh
seek
medic
advic
earli
report
potenti
exposur
chicken
poultri
even
fleetingli
sever
airborn
transmit
diseas
like
tuberculosi
human
influenza
caus
small
outbreak
within
confin
aircraft
buse
train
given
low
transmiss
potenti
virus
travel
assur
travel
air
etc
safe
evalu
return
travel
fever
bread
butter
travel
medicin
doctor
gener
practition
also
awar
seriou
ill
recent
return
travel
refer
patient
quickli
evalu
sever
review
fever
return
travel
risk
travel
extrem
low
earli
clinic
manifest
mimic
figur
chest
xray
seri
adult
male
patient
fatal
admit
day
ill
admiss
cxr
show
opacif
right
mid
zone
outlin
horizont
fissur
obscur
right
heart
border
keep
middl
lobe
consolid
day
develop
addit
right
lower
lobe
consolid
demonstr
obscur
right
hemidiaphragm
day
patient
intub
complet
opacif
right
hemithorax
left
perihilar
consolid
like
repres
addit
pulmonari
oedema
littl
radiograph
chang
day
cxr
done
day
day
parenchym
opacif
stabl
moder
right
pleural
effus
die
day
febril
ill
like
flu
malaria
dengu
enter
fever
think
requir
high
index
suspicion
awar
case
definit
avian
influenza
box
may
help
guid
take
good
histori
especi
regard
potenti
exposur
http
http
wwwcdcgov
fluavianprofessionalguidancelabtestinghtm
patient
present
predominantli
respiratori
ill
respiratori
pathogen
may
thought
box
adapt
advic
offer
travel
uk
health
protect
agenc
us
cdc
http
wwwhpaorguk
http
wwwncdcgovtravelcontentavianfluasiaaspx
care
bird
avoid
visit
live
anim
market
poultri
farm
avoid
direct
contact
bird
includ
poultri
chicken
duck
wild
bird
avoid
touch
surfac
bird
drop
faec
bird
fluid
avoid
place
poultri
farm
bird
market
live
bird
rais
kept
pick
touch
dead
die
bird
eat
handl
undercook
raw
poultri
egg
poultri
blood
duck
dish
eat
bird
meat
product
thoroughli
cook
egg
yolk
runni
liquid
attempt
bring
live
poultri
product
back
uk
practic
healthi
habit
help
stop
spread
germ
wash
hand
often
soap
clean
water
remov
germ
skin
help
prevent
diseas
spread
use
waterless
alcoholbas
hand
gel
contain
least
alcohol
soap
clean
water
avail
hand
visibl
dirti
seek
medic
care
feel
sick
becom
sick
fever
plu
cough
sore
throat
troubl
breath
seek
medic
care
right
away
tell
doctor
contact
sick
dead
bird
suspect
case
person
present
unexplain
acut
lower
respiratori
ill
fever
c
cough
short
breath
difficulti
breath
one
follow
exposur
day
prior
symptom
onset
close
contact
within
person
eg
care
speak
touch
suspect
probabl
confirm
case
b
exposur
eg
handl
slaughter
defeath
butcher
prepar
consumpt
poultri
wild
bird
remain
environ
contamin
faec
area
infect
anim
human
suspect
confirm
last
month
c
consumpt
raw
undercook
poultri
product
area
infect
anim
human
suspect
confirm
last
month
close
contact
confirm
infect
anim
poultri
wild
bird
eg
cat
pig
e
handl
sampl
anim
human
suspect
contain
viru
laboratori
set
person
meet
criteria
suspect
case
one
follow
addit
criteria
infiltr
evid
acut
pneumonia
chest
radiograph
plu
evid
respiratori
failur
hypoxemia
sever
tachypnoea
b
posit
laboratori
confirm
influenza
infect
insuffici
laboratori
evid
infect
probabl
definit
person
die
unexplain
acut
respiratori
ill
consid
epidemiolog
link
time
place
exposur
probabl
confirm
case
eg
influenza
pneumococc
legionella
mycoplasma
pneumonia
lung
involv
also
character
number
system
tropic
infect
notabl
falciparum
vivax
malaria
sever
typhoid
fever
leptospirosi
typhu
melioidosi
also
import
consid
exist
coinfect
travel
even
may
present
appar
clear
cut
clinic
ill
mani
febril
ill
share
laboratori
featur
eg
low
total
white
cell
count
thrombocytopenia
mildli
rais
pt
aptt
rais
liver
enzym
mild
renal
impair
blood
eosinophilia
howev
would
make
unlik
experi
date
return
travel
limit
one
report
travel
suspect
avian
influenza
neg
posit
season
influenza
era
heighten
awar
mani
return
travel
test
like
neg
diagnost
face
number
possibl
diagnos
choos
appropri
diagnost
test
essenti
asid
routin
diagnost
test
order
febril
travel
obtain
good
qualiti
respiratori
specimen
crucial
specimen
consid
high
risk
label
biohazard
transport
laboratori
accord
guidelin
infect
specimen
patient
well
nasopharyng
np
sampl
either
aspir
npa
use
np
swab
sampl
choic
obtain
observ
necessari
infect
control
measur
fresh
specimen
prefer
laboratori
process
possibl
immedi
sampl
may
store
fridg
c
h
throat
nose
swab
also
taken
admiss
daili
thereaft
document
clearanc
viru
ventil
patient
endotrach
aspir
obtain
limit
experi
se
asia
show
endotrach
aspir
higher
yield
npa
turn
better
throat
nasal
swab
h
wertheim
unpublish
observ
current
avail
rapid
commerci
test
design
primarili
human
b
influenza
low
sensit
specif
reli
upon
diagnos
number
user
friendli
nucleic
acid
base
rapid
test
develop
detect
avail
futur
need
independ
evalu
refer
laboratori
present
best
way
diagnos
revers
transcriptas
polymeras
chain
reaction
rt
pcr
respiratori
specimen
rt
pcr
tell
physician
type
influenza
viru
ie
b
c
h
n
subtyp
eg
etc
result
may
take
h
laboratori
viral
subtyp
report
eg
influenza
subtyp
unknown
full
viru
characteris
need
done
refer
laboratori
real
time
rt
pcr
method
also
avail
measur
viral
load
system
diseas
detect
plasma
pleural
fluid
rectal
swab
csf
therefor
sampl
restrict
respiratori
tract
npa
swab
plasma
applic
post
mortem
biopsi
valuabl
specimen
store
failur
detect
may
mean
anoth
respiratori
ill
may
diagnos
store
specimen
serolog
pair
serum
sampl
diagnos
retrospect
detect
antibodi
haemagglutin
inhibit
hi
neutralis
two
princip
method
latter
sensit
detect
antibodi
day
post
infect
labour
intens
hi
requir
use
laboratori
famili
virus
compos
number
clade
strain
evid
date
suggest
differ
clade
similar
clinic
pictur
therapeut
import
vari
vitro
sensit
current
avail
antivir
drug
tabl
clade
intrins
sensit
clade
oseltamivir
experi
season
influenza
virus
sensit
virus
may
mutat
develop
reduc
sensit
neuraminidas
inhibitor
oseltamivir
zanamivir
peramivir
adamantan
amantadin
rimantadin
notabl
exampl
recent
rapid
emerg
global
season
non
swine
influenza
reduc
sensit
oseltamivir
due
mutat
absenc
oseltamivir
use
commun
mutat
confer
mark
increas
ic
oseltamivir
peramivir
season
data
adapt
le
et
al
hurt
et
al
mckimmbresckin
et
al
govorkova
et
al
review
avian
influenza
report
increas
vari
wide
fold
major
virus
remain
sensit
oseltamivir
oseltamivir
resist
emerg
oseltamivir
treatment
infect
patient
treat
mg
hourli
viru
found
mutat
monitor
vitro
sensit
influenza
virus
nation
refer
laboratori
within
global
neuraminidas
inhibitor
suscept
network
import
surveil
activ
sourc
date
inform
treatment
number
regist
antivir
drug
limit
oral
amantadin
rimantadin
oseltamivir
inhal
zanamivir
intraven
zanamivir
develop
avail
compassion
use
name
patient
basi
iv
peramivir
file
registr
japan
authoris
use
usa
us
food
drug
administr
fda
pandem
neuraminidas
inhibitor
inhibit
viral
neuraminidas
break
bond
newli
form
virion
sialic
acid
receptor
epitheli
cell
surfac
thu
prevent
releas
adamantan
inhibit
ion
channel
function
matrix
protein
result
failur
viru
uncoat
infect
cell
current
mainstay
treatment
avian
influenza
oral
oseltamivir
alon
recent
retrospect
data
suggest
oseltamivir
may
reduc
mortal
half
compar
untreat
patient
intersci
confer
antimicrobi
agent
chemotherapi
icaac
abstract
publish
experi
use
antivir
combin
human
anim
data
suggest
oseltamivir
plu
ribavirin
amantadin
plu
oseltamivir
synergist
latter
amantadin
sensit
viru
anim
studi
may
pave
way
trial
human
optim
dose
antivir
drug
form
sever
influenza
evalu
rigor
randomis
trial
given
rariti
trial
may
never
conduct
one
ongo
studi
evalu
doubl
versu
standard
dose
oseltamivir
treatment
sever
season
influenza
vietnam
indonesia
thailand
auspic
sea
infecti
diseas
clinic
research
network
www
seaicrnorg
recommend
dose
antivir
base
mild
human
influenza
recommend
physician
consid
doubl
dose
oseltamivir
sever
ill
patient
howev
alreadi
common
practic
sever
swine
countri
like
vietnam
indonesia
somewhat
cautiou
approach
seem
unwarr
proper
dose
rang
studi
need
determin
optim
dose
oseltamivir
alon
combin
amantadin
rimantadin
dose
use
human
influenza
ad
infect
clade
known
sensit
eg
clade
northern
vietnam
clade
adamantan
narrow
therapeut
index
oseltamivir
well
toler
thu
limit
possibl
increas
dose
use
combin
may
reduc
probabl
develop
resist
treatment
oseltamivir
oseltamivir
phosphat
parent
drug
well
absorb
patient
mild
influenza
short
half
life
h
prodrug
lack
antivir
activ
metabolis
antivir
activ
oseltamivir
carboxyl
oc
given
hourli
uncertainti
surround
absorpt
oseltamivir
sever
ill
influenza
patient
partli
resolv
small
clinic
seri
oseltamivir
well
absorb
achiev
higher
steadi
state
plasma
concentr
compar
mild
influenza
patient
renal
impair
lower
volum
distribut
w
taylor
unpublish
data
base
small
number
patient
date
viral
clearanc
throat
swab
occur
within
day
oseltamivir
treatment
whether
repres
lung
unknown
continu
viral
replic
despit
oseltamivir
document
associ
death
given
high
mortal
even
doubl
dose
oseltamivir
alon
fail
clearli
revers
patholog
mani
patient
may
also
document
viral
clearanc
optim
oseltamivir
dose
sever
influenza
remain
determin
oc
renal
excret
glomerular
filtrat
secret
human
anion
transport
proxim
tubul
manufactur
recommend
dose
oseltamivir
halv
renal
diseas
crcl
mlmin
oc
loss
via
haemofilt
haemofiltr
low
top
dose
requir
revers
true
haemodialysi
hd
two
third
oc
concentr
lost
h
hd
session
top
dose
given
dialysi
w
taylor
unpublish
data
optim
oseltamivir
dose
patient
renal
impair
unknown
oseltamivir
usual
well
toler
dose
relat
side
effect
gener
confin
headach
nausea
vomit
despit
dose
mg
given
hourli
post
market
surveil
number
sever
advers
event
observ
like
steven
johnson
syndrom
cardiac
arrhythmia
report
often
difficult
ascrib
drug
given
sever
poor
prognosi
physician
overli
concern
oc
induc
toxic
patient
mani
ventil
role
amantadin
rimantadin
limit
presenc
gene
mutat
mani
isol
confer
adamantan
resist
human
influenza
develop
clinic
resist
treatment
well
describ
like
occur
adamantan
use
alon
therefor
amantadin
rimantadin
alway
use
combin
anoth
antivir
drug
rimantadin
fewer
central
nervou
system
toxic
eg
hyperexcit
slur
speech
tremor
insomnia
dizzi
psychosi
convuls
amantadin
prefer
side
effect
relat
cross
blood
brain
barrier
wors
higher
plasma
concentr
consequ
impair
renal
function
therefor
dose
reduct
requir
renal
diseas
pk
interact
oseltamivir
amantadin
toler
similar
drug
given
individu
human
normal
volunt
amantadin
cross
placenta
associ
toxic
anim
studi
also
associ
rare
teratogen
lesion
infant
born
mother
first
trimest
exposur
publish
data
rimantadin
avoid
pregnanc
major
patient
hospit
seri
develop
acut
respiratori
distress
syndrom
impair
organ
requir
intens
care
mechan
ventil
optim
ventilatori
set
unknown
ard
network
guidelin
lung
protect
ventil
recommend
pend
research
data
base
uncontrol
observ
data
high
dose
supplementari
corticosteroid
recommend
use
patient
may
associ
increas
mortal
howev
steroid
may
given
patient
sever
diseas
evid
lack
sever
ill
patient
much
clinician
appli
principl
recommend
formul
treat
patient
eg
sever
sepsi
limit
appar
favour
experi
intraven
immunoglobulin
administr
serum
chines
patient
patient
recov
done
also
flu
pandem
sever
group
develop
neutralis
monoclon
antibodi
use
passiv
immun
immunomodulatori
therapi
explor
therapeut
option
combin
antivir
drug
avian
influenza
danger
diseas
suspect
case
immedi
report
local
public
health
author
confirm
case
report
although
risk
persontoperson
transmiss
low
date
zero
case
fatal
rate
extrem
high
therefor
patient
admit
suspect
avian
influenza
consid
infecti
appropri
infect
control
measur
institut
guidanc
infect
control
expert
includ
patient
isol
prefer
neg
pressur
room
restrict
visitor
full
respiratori
droplet
protect
health
staff
care
patient
ie
glove
goggl
respir
eg
gown
secondari
case
occur
famili
member
care
confirm
case
therefor
health
surveil
postexposur
oseltamivir
prophylaxi
close
contact
confirm
case
consid
learn
infect
passag
time
research
earli
infect
may
decept
mild
may
thought
differenti
diagnosi
mortal
remain
high
despit
use
antivir
drug
pretravel
consult
includ
advic
prevent
travel
doctor
like
see
patient
suspect
part
work
therefor
need
differenti
diagnosi
along
number
respiratori
system
fever
earli
diagnosi
key
obtain
necessari
respiratori
specimen
rt
pcr
essenti
conflict
interest
author
